News for 'Subject Expert Committee'

Watching global Covid spread, IIT-Kanpur has not predicted 4th wave: Govt

Watching global Covid spread, IIT-Kanpur has not predicted 4th wave: Govt

Rediff.com22 Mar 2022

Noting that various mathematical models meant for predicting coronavirus waves have repeatedly failed to give reliable results due to a small sample size, the Centre on Tuesday said it is closely following the virus trajectory globally, given the emergence of its new variants.

Bharat Biotech asked to submit phase 2 data of its Covid vaccine

Bharat Biotech asked to submit phase 2 data of its Covid vaccine

Rediff.com10 Oct 2020

The vaccine candidate -- 'Covaxin' -- is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

Rediff.com19 Jul 2021

So far, no other vaccine has been approved globally for children below 12 years. Sohini Das reports.

Right Time To Invest In Silver ETFs?

Right Time To Invest In Silver ETFs?

Rediff.com29 Oct 2024

Invest with a 5 to 7 year horizon so that you are able to ride out price volatility and benefit from the long-term trends of demand and macroeconomic shifts.

Probe report blows lid off sexual harassment in Mollywood

Probe report blows lid off sexual harassment in Mollywood

Rediff.com19 Aug 2024

The much-awaited report of the Justice Hema Committee, the government-appointed panel in 2019 that studied issues faced by women in the Malayalam film industry, comprises explosive accounts of harassment, exploitation, and ill-treatment being faced by women.

Rise above politics, consider shifting Kuno cheetahs to Raj, SC tells Centre

Rise above politics, consider shifting Kuno cheetahs to Raj, SC tells Centre

Rediff.com18 May 2023

A bench of justices BR Gavai and Sanjay Karol told the Centre that from reports of experts and articles, it appears that KNP does not seem to be sufficient for such large number of cheetahs and the Union government may consider shifting them to other sanctuaries.

New Bill May Throttle OTT

New Bill May Throttle OTT

Rediff.com7 Dec 2023

'Subjecting each such creative content to scrutiny will impose burdens on the OTT platforms and impact user experience.'

Covaxin gets nod for use in children above 12 years with riders

Covaxin gets nod for use in children above 12 years with riders

Rediff.com25 Dec 2021

The Subject Expert Committee on COVID-19 of the CDSCO on October 12 after deliberating Bharat Biotech's EUA application had recommended granting emergency use approval to Covaxin for use in the 12-18 years age group with certain conditions.

Can't take media reports as gospel truth, says SC, backs SEBI on Adani probe

Can't take media reports as gospel truth, says SC, backs SEBI on Adani probe

Rediff.com24 Nov 2023

The Supreme Court on Friday said it has no reason to "discredit" SEBI, which probed allegations against the Adani group, as there was no material before it to doubt what the market regulator has done and the court does not have to treat what was set out in the Hindenburg report as a "true state of affairs".

Will NGT call the Yamuna expert panel's bluff?

Will NGT call the Yamuna expert panel's bluff?

Rediff.com11 May 2017

The Art of Living case will go down as a test for environment activism in the country, notes M Rajaque Rahman.

Serum Institute seeks regular marketing approval for Covishield

Serum Institute seeks regular marketing approval for Covishield

Rediff.com25 Oct 2021

If the DCGI grants regular marketing authorisation, Covishied will be the second vaccine in the world to receive such approval.

DGCI denies emergency use nod to Sputnik-Light vaccine

DGCI denies emergency use nod to Sputnik-Light vaccine

Rediff.com1 Jul 2021

According to the recommendations of the Subject Expert Committee (SEC) meeting held on July 30, which have been approved by the Drugs Controller General of India (DCGI), Sputnik-Light is the same as the component-1 of Sputnik V and as its safety and immunogenicity data in the Indian population has already been generated in a trial here, there seems to be inadequate data and justification for conducting a separate, similar trial.

Parl panel advises caution in emergency approval of vaccine

Parl panel advises caution in emergency approval of vaccine

Rediff.com21 Dec 2020

In a report submitted Monday to Rajya Sabha chairman and Vice President M Venkaiah Naidu, the Parliamentary Standing Committee on Home Affairs also said there was a need for a comprehensive public health law to keep a tab on private hospitals and check black-marketing of medicines.

Indian pharma firms working on new repurposed drug for Covid-19

Indian pharma firms working on new repurposed drug for Covid-19

Rediff.com2 Sep 2020

Many companies globally are working on plasma research to develop and manufacture hyperimmune globulin therapies from plasma donations.

Where Would India Be Without Dr Singh?

Where Would India Be Without Dr Singh?

Rediff.com27 Dec 2024

What stood out in his 15-year journey as a member of the political executive at the Centre was his glowing record as India's most successful and effective finance minister. Both as prime minister and finance minister, he understood the importance of gradualism, except when the economy or the polity was in a crisis.

Covaxin safe for children: Bharat Biotech

Covaxin safe for children: Bharat Biotech

Rediff.com31 Dec 2021

Bharat Biotech is targeting to manufacture one billion doses of its intra-nasal vaccine in 2022 which is under clinical trials now.

Corbevax cleared for kids in 5-12 yrs age group, Covaxin for 6-12

Corbevax cleared for kids in 5-12 yrs age group, Covaxin for 6-12

Rediff.com26 Apr 2022

The approval by the Drugs Controller General of India comes following recommendations by the Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation.

Bharat Biotech gets nod for phase 1 clinical trials of nasal vaccine

Bharat Biotech gets nod for phase 1 clinical trials of nasal vaccine

Rediff.com19 Jan 2021

Bharat Biotech applied to the Drugs Controller General of India (DCGI) seeking permission for conducting phase 1 and phase 2 clinical trials of the intranasal vaccine following which the subject expert committee of the CDSCO on Tuesday deliberated on the application and recommended granting permission for phase 1 trial.

June 22 GST Council meet may give relief to foreign airlines

June 22 GST Council meet may give relief to foreign airlines

Rediff.com21 Jun 2024

The Goods and Services Tax (GST) Council, scheduled to meet on June 22, could take a call on ending uncertainty on taxing foreign airlines and shippers as regards certain services, a senior official in the know told Business Standard. He said the Council was expected to decide on exempting the services in question from GST - aircraft lease rentals, maintenance, crew salaries, etc. These services are provided by foreign airlines to their Indian operations.

Bio E gets nod for kids' phase 2, 3 Covid vax trial

Bio E gets nod for kids' phase 2, 3 Covid vax trial

Rediff.com3 Sep 2021

Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology (DBT) said on Friday.

Pharma majors shift focus to inhalants, nasal spray for Covid

Pharma majors shift focus to inhalants, nasal spray for Covid

Rediff.com30 Aug 2021

While Lupin is working on a Remdesivir powder for inhalation, Glenmark has tied up with a Canadian Biotech firm for nitric oxide nasal spray that reduces Sars-CoV-2 viral load and thus transmission.

'Please let us compete in Paris, we need mental peace before Olympics'

'Please let us compete in Paris, we need mental peace before Olympics'

Rediff.com17 May 2024

Paris Games quota-winning women wrestlers on Friday pleaded with the national federation not to subject them to selection trials, saying that every single step they take and every little thing they do from now on will have a bearing on India's medal chances at the Olympics.

Why one more plea on Manipur, mention it to CJI, SC tells petitioner

Why one more plea on Manipur, mention it to CJI, SC tells petitioner

Rediff.com27 Jul 2023

The Supreme Court on Thursday asked a petitioner, who has sought the constitution of an independent committee under a retired apex court judge to inquire into the incidents of sexual assault and violence in Manipur, to mention his plea for listing before a bench headed by Chief Justice D Y Chandrachud.

Sudha Murty, Shankar Mahadevan in NCERT panel to develop new textbooks

Sudha Murty, Shankar Mahadevan in NCERT panel to develop new textbooks

Rediff.com12 Aug 2023

The 19-member National Syllabus and Teaching Learning Material Committee (NSTC) will be headed by National Institute of Educational Planning and Administration (NIEPA) chancellor MC Pant and develop textbooks for classes 3 to 12.

NCERT panel for replacing 'India' with 'Bharat' in textbooks

NCERT panel for replacing 'India' with 'Bharat' in textbooks

Rediff.com25 Oct 2023

The committee has also recommended highlighting 'Hindu victories' in various battles in the textbooks.

How HUL plans to serve the customers of tomorrow

How HUL plans to serve the customers of tomorrow

Rediff.com11 Dec 2023

Hindustan Unilever (HUL)'s decision to split its beauty and personal care division and place a renewed focus on digital has been driven by its aim to serve the consumer of tomorrow, say analysts and brand experts. HUL managing director and chief executive officer Rohit Jawa is looking to make the company 'future ready', and while these bets are not for the short-term, they will eventually pay off as the Indian consumer is young and digital friendly, they add. "Rohit Jawa comes with digital experience and he is preparing to steer HUL into serving the future consumer who is more digital friendly," said Sachin Bobade, vice-president at brokerage firm Dolat Capital.

Tracking non-food retail inflation trends in India

Tracking non-food retail inflation trends in India

Rediff.com4 Sep 2024

Amid a debate on the basis of a monetary policy stance, one may be curious enough to know how non-food retail inflation has behaved over the years in India. Let the eager souls catch a glimpse of facts. In the past 10 years, non-food inflation came down below 4 per cent on two occasions - pre-Covid period of 2019-20 and now in the first four months of the current financial year (FY25).

Serum Institute ready to roll out Covid vaccine

Serum Institute ready to roll out Covid vaccine

Rediff.com3 Jan 2021

The Pune-based vaccine major has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine.

Cheetahs developed Africa's winter fur in Kunoh's summer, govt tells SC

Cheetahs developed Africa's winter fur in Kunoh's summer, govt tells SC

Rediff.com7 Aug 2023

The central government's ambitious Project Cheetah is facing a major problem, with the animals translocated from South Africa developing a "winter cover", a thick coat of fur, in anticipation of African winter, the Supreme Court was told on Monday.

HC to hear Gyanvapi plea on Thursday, extends stay on ASI survey

HC to hear Gyanvapi plea on Thursday, extends stay on ASI survey

Rediff.com26 Jul 2023

The Allahabad high court on Wednesday extended the stay on a survey of the Gyanvapi mosque premises by the Archaeological Survey of India till Thursday.

'Markets Not In Panic Yet, But...'

'Markets Not In Panic Yet, But...'

Rediff.com7 Oct 2024

'If you see another 1000-point correction, people may start panicking.'

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Rediff.com25 Aug 2021

If things go according to plan, the vaccine would be available in the market by the end of this year.

India's Sputnik V decision a win for Russia's soft power diplomacy

India's Sputnik V decision a win for Russia's soft power diplomacy

Rediff.com20 Apr 2021

The Russian vaccine has been registered in more than 55 countries and is gaining recognition in the virtual world -- being the only to have its own Facebook page, YouTube channel and a Twitter handle, reports Aneesh Phadnis

Bihar 'topper' Ruby Rai sent to judicial custody

Bihar 'topper' Ruby Rai sent to judicial custody

Rediff.com26 Jun 2016

The Bihar State Examination Board Class 12 arts topper was on Saturday taken into custody by Patna Police's Special Investigation Team soon after she failed the re-test.

Enough stockpile of COVID-19 vaccine for priority groups: Niti member

Enough stockpile of COVID-19 vaccine for priority groups: Niti member

Rediff.com4 Jan 2021

Paul noted that "three to four months from now, there will be other vaccines and the stockpile will be even bigger. "And more acceleration can be brought about in the vaccination programme," Paul added.

Should You Invest In Gilt Funds?

Should You Invest In Gilt Funds?

Rediff.com4 Jul 2024

By taking the mutual fund route, investors can take exposure to gilts with small amounts. Over a decade or more, returns from these funds tend to be sound.

RBI extends loan restructuring facility to India Inc

RBI extends loan restructuring facility to India Inc

Rediff.com6 Aug 2020

Stressed MSME borrowers would be eligible for restructuring of debt, if their accounts were classified standard.

DGCA lists steps to deal with hacking aircraft navigation system

DGCA lists steps to deal with hacking aircraft navigation system

Rediff.com24 Nov 2023

Aviation watchdog DGCA has issued a circular to airlines and the Airports Authority of India (AAI) on measures to deal with threats from jamming and spoofing of the Global Navigation Satellite System (GNSS) amid reports of such interference in the Middle East.

Police Get More Powers Under New Laws

Police Get More Powers Under New Laws

Rediff.com1 Jul 2024

Lawyers have pointed out that the new laws increase police powers by extending the maximum limit of police custody from 15 days to 60 days or 90 days.

DCGI finds no link between Covid vaccine shot and 'adverse' reaction

DCGI finds no link between Covid vaccine shot and 'adverse' reaction

Rediff.com2 Dec 2020

The DCGI arrived at the conclusion on Wednesday based on the recommendations of an independent expert committee which has also opined that compensation should not be paid to the volunteer, they said.